Ivermectin

Ivermectin is an antiparasitic medication that has shown anti-cancer properties in laboratory studies and early clinical research. Studies suggest it may inhibit tumor growth, induce cancer cell death, and affect multiple pathways involved in cancer progression, though human clinical data remains limited.

Why Ivermectin Is Being Studied for Cancer

  • May inhibit cancer cell proliferation through multiple mechanisms

  • Shows potential to induce apoptosis and autophagy in tumor cells

  • Demonstrates ability to inhibit cancer stem cell renewal

  • May enhance effectiveness of chemotherapy drugs

  • Well-established safety profile from decades of antiparasitic useCancer Types Being Studied

Cancer Types Being Studied

  • Breast cancer

  • Colorectal cancer

  • Leukemia

  • Ovarian cancer

  • Glioblastoma

  • Melanoma

Related Topics in Our Archive

  • Ivermectin cancer research

  • Ivermectin and chemotherapy

  • Ivermectin apoptosis

  • Ivermectin dosage cancer

  • Ivermectin cancer stem cells

Common Research Questions

  • What dosages are being studied for cancer?

  • Does ivermectin interact with chemotherapy drugs?

  • What is the current state of clinical trial evidence?

  • What are potential side effects at higher doses?

What Researchers Are Studying

  • Mechanisms of anti-cancer action

  • Optimal dosing for oncology applications

  • Combination with standard treatments

  • Clinical trial development and outcomes

Browse Ivermectin Research

→ Search our archive for "ivermectin"

Disclaimer

This page is for informational purposes only. Always consult your oncologist before adding any supplement to your treatment plan.